Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Dr. Gillian Mahumane | Pharmaceutical science | Best Researcher Award

Lecturer at University of the Witwatersrand, South Africa

Dr. Gillian D. Mahumane is a pharmaceutical scientist and lecturer whose research advances neural-targeted and vaginal drug delivery systems with a strong focus on translational pharmaceutics and global health impact. Her work spans innovative platforms such as antimicrobial cryogels, polymeric films, and nanofiber scaffolds for applications in neural repair and women’s health. She has published extensively in peer-reviewed journals, contributed to book chapters, and presented at international conferences, establishing her as a thought leader in advanced drug delivery. Beyond research, she is deeply committed to mentorship, supervising postgraduate students, co-founding research support initiatives, and shaping biopharmaceutics curricula to bridge science and practice. Recognition through prestigious fellowships and membership in the Global Young Academy highlights her growing leadership in science communication, innovation management, and policy engagement. Combining scientific excellence, mentorship, and advocacy, Dr. Mahumane exemplifies a new generation of researchers dedicated to advancing biomedical innovation and societal health impact.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Gillian D. Mahumane has built a solid academic foundation in pharmaceutical sciences through progressive qualifications at the University of the Witwatersrand. She completed her Bachelor of Pharmacy, where her early research explored drug delivery using polycaprolactone-based systems. Building on this, she earned her Master of Pharmacy with distinction, focusing on the antimicrobial activity and chemical analysis of Eucalyptus radiata essential oil, which deepened her expertise in natural products and pharmaceutical analysis. Her doctoral studies marked a significant step into advanced biomaterials and regenerative medicine, culminating in a PhD in which she designed and evaluated nano-reinforced hydro-filled 3D scaffolds for neural tissue engineering. This multidisciplinary training equipped her with expertise in pharmaceutics, biomaterials, and pharmacokinetics, forming the basis for her later research into neural-targeted and vaginal drug delivery platforms. Her academic journey reflects both depth in specialized research and breadth across pharmaceutical sciences, positioning her for leadership in translational pharmaceutics.

Experience

Dr. Gillian Mahumane is a lecturer in biopharmaceutics and a researcher with the Wits Advanced Drug Delivery Platform, where she combines teaching, mentorship, and cutting-edge research. Her role encompasses supervising postgraduate projects, integrating research into curriculum design, and driving institutional research support strategies. She has gained valuable international experience through fellowships with the Population Council’s Centre for Biomedical Research in New York, focusing on vaginal drug delivery innovation, and the UCL-Wits Public Voices Fellowship, which enhances her leadership in science communication. In addition to her academic contributions, she has engaged in policy-linked research initiatives and co-founded a research support group that mentors over thirty postgraduate students. Her professional journey is defined by a balance of laboratory innovation, translational research, and capacity building. Through these roles, she has cultivated expertise not only as a scientist but also as an educator, mentor, and emerging leader in pharmaceutical innovation and global health.

Research Focus

Dr. Gillian Mahumane’s research is anchored in translational pharmaceutics, particularly neural-targeted and vaginal drug delivery systems designed to address unmet clinical needs. She has explored advanced biomaterials, including nanofiber scaffolds, polymeric films, and antimicrobial cryogels, with applications ranging from brain tissue regeneration to intravaginal microbicide delivery. Her doctoral research pioneered nano-reinforced hydro-filled 3D scaffolds for neural repair, addressing challenges in tissue engineering and regenerative medicine. More recently, she has advanced vaginal platforms for multipurpose prevention technologies, integrating biopharmaceutics and global health perspectives. Complementing these laboratory innovations, she contributes to pharmacokinetics research, designing teaching models and patient-centered dosage regimens. Her focus extends beyond discovery to translation, aiming to move research outputs into real-world applications that improve health outcomes. By integrating pharmaceutical sciences, biomaterials engineering, and policy engagement, her research not only contributes to academic knowledge but also supports broader societal impact in women’s health and neurotherapeutics.

Award and Honor

Dr. Gillian Mahumane has been recognized with multiple awards and fellowships that underscore both her scientific excellence and her emerging leadership in global health research. She is a member of the Global Young Academy, an honor that acknowledges her as a voice for African biomedical innovation and positions her within an influential international network of scientists. Her selection as a CBR/Jeiven Fellow at the Population Council in New York highlighted her contributions to vaginal drug delivery innovation, while her UCL-Wits Public Voices Fellowship reflects her strength in science communication and policy engagement. She has also been featured in initiatives promoting women in science, innovation in pharmaceutical education, and capacity building in Africa. Beyond formal fellowships, her research and teaching have been showcased through institutional awards, invited talks, and international conference presentations. These recognitions emphasize not only her scholarly achievements but also her commitment to mentorship, innovation, and societal health impact.

Publication Top Notes

Title: 3D scaffolds for brain tissue regeneration: architectural challenges
Authors: GD Mahumane, P Kumar, LC du Toit, YE Choonara, V Pillay
Year: 2018
Citations: 90

Title: Repositioning N-Acetylcysteine (NAC): NAC-Loaded Electrospun Drug Delivery Scaffolding for Potential Neural Tissue Engineering Application
Authors: GD Mahumane, P Kumar, V Pillay, YE Choonara
Year: 2020
Citations: 29

Title: Chemical composition and antimicrobial activity of Eucalyptus radiata leaf essential oil, sampled over a year
Authors: GD Mahumane, SF van Vuuren, G Kamatou, M Sandasi, AM Viljoen
Year: 2016
Citations: 13

Title: Impact of illegible prescriptions on dispensing practice: a Pilot Study of South African Pharmacy Personnel
Authors: T Modi, N Khumalo, R Shaikh, Z Booth, S Leigh-de Rapper, GD Mahumane
Year: 2022
Citations: 9

Title: Antimicrobial activity and chemical analysis of Eucalyptus radiata leaf essential oil
Author: GD Mahumane
Year: 2016
Citations: 5

Title: A review of bigels for neurotrauma therapeutics: Structural insights for tissue microenvironment alignment
Authors: YC Botle Moswatsi, GD Mahumane, Pradeep Kumar
Year: 2025
Citations: 1

Title: The potential for Eucalyptus radiata leaf essential oil use as a commercial antimicrobial
Authors: GD Mahumane, SF van Vuuren, AM Viljoen, G Kamatou
Year: 2015
Citations: 1

Title: A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Analysis
Authors: PL Khonzisizwe Somandi, TS Mwale, M Sobiech, D Klejn, GD Mahumane, YE Choonara, J Giebułtowicz, P Luliński
Year: 2025

Title: Bio-inspired nanofibres: Weaving biological tissue with nanomedicine to repair brains
Authors: GD Mahumane, YE Choonara
Year: 2022

Title: Nano-enabled systems for neural tissue regenerative applications
Authors: GD Mahumane, P Kumar, YE Choonara
Year: 2022

Title: Nano-reinforced hydro-filled 3D scaffold for neural tissue engineering (PhD Thesis)
Author: GD Mahumane
Year: 2021

Conclusion

Dr. Gillian D. Mahumane has established a strong and growing research portfolio in pharmaceutical sciences, with particular strengths in neural tissue engineering, vaginal drug delivery platforms, and biomaterials innovation. Her most-cited works, such as those on 3D scaffolds for brain tissue regeneration and electrospun drug delivery systems, highlight her contributions to advancing regenerative medicine and translational pharmaceutics. In addition, her studies on natural products and antimicrobial applications demonstrate her versatility across pharmaceutical research domains. While some of her most recent publications are still in the early stages of gaining citations, they reflect cutting-edge directions in drug delivery and biomedical innovation. Taken together, her body of work illustrates both academic impact and practical relevance, positioning her as a promising and influential researcher. With continued advancement of her translational outputs and expanded global collaborations, Dr. Mahumane is well-placed to make sustained contributions worthy of recognition through research excellence awards.

Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Prof. Sireen Abdulrahim Shilbayeh | Clinical Pharmacy | Best Researcher Award

Professor at Princess Nora University, Pharmacy College, Riyadh, Saudi Arabia

Professor Sireen Abdulrahim Shilbayeh is a distinguished academic in clinical pharmacy with over two decades of experience in teaching, research, and healthcare practice. She earned her Ph.D. in Clinical Pharmacy Practice from the University of Nottingham, UK, specializing in pharmaceutical and health outcomes research, particularly the meta-analysis of antiarrhythmic drug trials. Currently a professor at Princess Nourah University in Riyadh, Saudi Arabia, she has held several key academic and administrative roles, including department head and scientific committee member. Her core strengths include evidence-based clinical practice, curriculum development, and interprofessional collaboration. She has been recognized with multiple institutional awards for research excellence and productivity. Her scholarly contributions span clinical trials, systematic reviews, and pharmacy education, supported by active participation in international conferences. Professor Shilbayeh is committed to advancing pharmacy practice through impactful research, academic leadership, and the mentoring of future healthcare professionals.

🔹Professional Profile 

Google Scholar
Scopus Profile 

🏆Strengths for the Award

Professor Shilbayeh demonstrates a distinguished and consistent record of academic and research achievements. Her doctoral training from the University of Nottingham, UK, focused on high-impact, evidence-based clinical pharmacy research, particularly in meta-analysis and systematic reviews—areas that are fundamental to improving clinical decision-making and healthcare outcomes.

Her long-standing academic trajectory, progressing from Assistant to Full Professor, across multiple universities, reflects both resilience and recognition of her scholarly contributions. She has served in prestigious roles, including chair memberships in university scientific councils and IRB committees, indicating peer trust and leadership in research governance.

Further, she has received multiple awards for research excellence from Princess Nourah University, particularly for prolific output in health sciences—a strong testament to her research productivity and impact. Her work on antiarrhythmic drug evaluations and pharmacoepidemiology, combined with over two decades of conference participation, showcases her dedication to scientific dissemination and continuing professional development.

🎓 Education

Professor Sireen Abdulrahim Shilbayeh holds a strong academic foundation in pharmaceutical sciences. She began her studies at King Saud University in Riyadh, Saudi Arabia, where she earned her Bachelor’s degree in Pharmacy. Seeking to further her education, she pursued postgraduate studies at the University of Nottingham in the United Kingdom. There, she completed an MPhil in Clinical Pharmacy, focusing on systematic reviews of clinical trials, followed by a Ph.D. in Clinical Pharmacy Practice. Her doctoral research specialized in the meta-analysis of randomized clinical trials involving antiarrhythmic drugs, combining rigorous scientific methodology with practical clinical implications. Throughout her academic journey, she developed a comprehensive understanding of clinical pharmacy, pharmacoepidemiology, and pharmaceutical care. Her education has been instrumental in shaping her evidence-based research approach, teaching philosophy, and ability to lead complex projects in academia and healthcare. These qualifications have paved the way for her successful academic and professional career in the region and beyond.

💼 Experience

Professor Shilbayeh brings over 25 years of academic and clinical experience in pharmacy. She began her professional career as a pharmacist at King Khaled University Hospital in Riyadh, gaining hands-on experience in inpatient and outpatient services, IV preparation, and drug information. She later worked as a clinical researcher at Nottingham University Hospital, focusing on cardiovascular pharmacotherapy. Her academic journey includes positions at Applied Science University and Al-Zytoonah University in Jordan, where she progressed from Assistant to Associate Professor. Since 2010, she has been affiliated with Princess Nourah University, where she became a Full Professor in 2015. Beyond teaching, she has served in several administrative capacities, including Head of the Clinical Pharmacy Practice Department, and as a member of the Institutional Review Board, Scientific Council, and Development Committees. Her career is marked by a blend of teaching excellence, research leadership, and a commitment to advancing clinical pharmacy education and healthcare practices.

🏅Awards and Honors

Professor Sireen Shilbayeh has received multiple accolades recognizing her contributions to research and academia. Among her most notable honors is the Excellence in Research Productivity Award from Princess Nourah University, awarded across all health-related faculties. This prestigious recognition highlights her extensive research output and impact within the healthcare sector. Additionally, she received an Appreciation Award from the University’s Graduate and Research Agency for her distinguished publications in indexed international journals. These awards reflect her dedication to scholarly excellence, continuous engagement with high-quality research, and leadership within the academic community. Her ability to maintain consistent output while supporting academic development and policy initiatives has earned her widespread respect. These honors also serve as acknowledgment of her commitment to raising standards in pharmacy practice and education, both regionally and internationally. Her achievements continue to inspire colleagues and students, solidifying her reputation as a leading figure in clinical pharmacy research.

🔬 Research Focus on Clinical Pharmacy

Professor Shilbayeh’s research centers on clinical pharmacy practice, with a strong emphasis on evidence-based medicine, pharmaceutical care, and health outcomes research. Her early work, including her doctoral dissertation, focused on the meta-analysis of antiarrhythmic drug trials, contributing valuable insights into cardiology-related pharmacotherapy. She is deeply involved in systematic reviews, pharmacoepidemiology, and comparative effectiveness research, ensuring her findings have direct clinical relevance. Her scholarly interests also span patient-centered care, drug safety, and therapeutic decision-making, aiming to improve the quality and efficiency of healthcare delivery. She frequently collaborates on projects addressing chronic disease management and clinical interventions in pharmacy practice. Through her work on the Institutional Review Board, she contributes to research ethics and the development of robust study designs. Her research not only informs clinical practice but also plays a key role in curriculum development and training for future pharmacists, emphasizing scientific rigor and real-world application.

📚 Publications Top Notes

  • Title: Prevalence of osteoporosis and its reproductive risk factors among Jordanian women: a cross-sectional study
    Authors: S. Shilbayeh
    Year: 2003
    Citations: 114

  • Title: Exploring knowledge and attitudes towards counselling about vitamin supplements in Jordanian community pharmacies
    Authors: S.A. Shilbayeh
    Year: 2011
    Citations: 42

  • Title: Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic
    Authors: S.A.R. Shilbayeh, W.A. Almutairi, S.A. Alyahya, N.H. Alshammari, E. Shaheen, et al.
    Year: 2018
    Citations: 40

  • Title: University students’ knowledge, attitudes, and practices towards the national premarital screening program of Saudi Arabia
    Authors: M. Melaibari, S. Shilbayeh, A. Kabli
    Year: 2017
    Citations: 35

  • Title: Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India
    Authors: H. Sharma, A. Ilyas, A. Chowdhury, N.K. Poddar, A.A. Chaudhary, et al.
    Year: 2022
    Citations: 29

  • Title: The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients
    Authors: S. Shilbayeh, R. Zmeili, R.I. Almardini
    Year: 2013
    Citations: 22

  • Title: A Markov Chain Model to Evaluate the Effect of CYP3A5 and ABCB1 Polymorphisms on Adverse Events Associated with Tacrolimus in Pediatric Renal Patients
    Authors: S.K.B. Sy, J. Heuberger, S. Shilbayeh, D.J. Conrado, H. Derendorf
    Year: 2013
    Citations: 19

  • Title: Pediatric renal transplantation in the Jordanian population: the clinical outcome measures during long-term follow-up period
    Authors: S. Shilbayeh, I. Hazza
    Year: 2012
    Citations: 17

  • Title: Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment
    Authors: S.A.R. Shilbayeh, S.K.B. Sy, M. Melhem, R. Zmeili, H. Derendorf
    Year: 2015
    Citations: 14

  • Title: Possible interethnic differences in omeprazole pharmacokinetics: comparison of Jordanian Arabs with other populations
    Authors: S. Shilbayeh, M.F. Tutunji
    Year: 2006
    Citations: 14

  • Title: Treatment satisfaction questionnaire for medication: validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, S.A. Alyahya, N.H. Alshammari, W.A. Almutairi, E. Shaheen
    Year: 2018
    Citations: 10

  • Title: The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients
    Authors: S. Shilbayeh
    Year: 2014
    Citations: 10

  • Title: Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Patients
    Authors: S.K.B. Sy, R.P. Singh, S. Shilbayeh, R. Zmeili, D. Conrado, H. Derendorf
    Year: 2013
    Citations: 9

  • Title: The anti-clot treatment scale (ACTS): validation of the translated Arabic version among patients undergoing warfarin therapy in Saudi Arabia
    Authors: S.A.R. Shilbayeh, A.A. Ibrahim
    Year: 2020
    Citations: 7

  • Title: Patient experience with an educational mobile health application: A pilot study on usability and feasibility in a Saudi population
    Authors: I.S.A. Shilbayeh, S.A. Shilbayeh
    Year: 2020
    Citations: 7

🏁 Conclusion

The Clinical Pharmacy Award is more than a recognition—it’s a platform to celebrate innovation, dedication, and impact in pharmaceutical care. By honoring professionals who excel in clinical practice, education, and research, this award promotes advancement in healthcare delivery and encourages the adoption of evidence-based, patient-centered approaches. Whether you’re an academic, clinician, or researcher, this is your opportunity to showcase your contributions to the evolving field of pharmacy. Apply now, inspire others, and join a distinguished network of leaders shaping the future of clinical pharmacy.